Samantha Tauchmann

Basel, BS 4031, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia.

MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia.

Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026

MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia.

MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia.

Journal: Blood cancer discovery
Published: November 20, 2025

Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation.

Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation.

Journal: Blood advances
Published: July 29, 2024

NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer.

NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer.

Journal: Life (Basel, Switzerland)
Published: July 14, 2021

Molecular Landscapes and Models of Acute Erythroleukemia.

Molecular Landscapes and Models of Acute Erythroleukemia.

Journal: HemaSphere
Published: January 18, 2021

NSD1 in erythroid differentiation and leukemogenesis.

NSD1 in erythroid differentiation and leukemogenesis.

Journal: Molecular & cellular oncology
Published: November 25, 2020

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Journal: Blood
Published: August 27, 2019

Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.

Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.

Journal: Nature communications
Published: August 08, 2019

Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma.

Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma.

Journal: Oncotarget
Published: February 05, 2018
Showing 1-9 of 9

Last Updated: 09/26/2026